Surface engineered nitrogen doped carbon quantum dots for mechanistic understanding and advanced biosensing of antibiotic contaminants: a review
Abstract
Nitrogen-doped carbon quantum dots (N-CQDs) have emerged as a versatile platform for antibiotic biosensing, yet the field has been hindered by empirical optimization without mechanistic understanding. This review establishes quantitative structure-property-performance relationships that enable rational sensor design. We demonstrate that surface chemistry tuning, specifically the density of carboxylic acid groups and the ratio of carboxylic acid to amino functionalities, governs tetracycline binding affinity, while nitrogen doping levels and their distribution among pyridinic, pyrrolic, and graphitic configurations determine the dominant charge transfer pathways. Pyridinic N is identified as an important contributor to photoinduced electron transfer, showing a reported correlation with Stern-Volmer constants (R 2 = 0.89) across available N-CQD systems; however, further validation using expanded datasets and statistical approaches is required to establish predictive QSPR relationships, while graphitic N facilitates electrochemical charge transport. The interplay between static quenching, dynamic quenching, and inner filter effects is systematically deconvoluted, revealing that 65-85% of the fluorescence response in optimized sensors arises from ground-state complex formation. Surface engineering strategies including heteroatom co-doping, aptamer functionalization, and metal-organic framework hybridization extend sensor capabilities to complex matrices, achieving recovery rates…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.